Life-Sciences-France.com
The French Life Sciences Web Portal

This is a free web portal for the life sciences in France and Monaco... » read more

CTC North Is Partner in HepB Vaccine H2020 Project TherVacB (2020-02-20)
On 1st January, 2020 a new research project in hepatitis B has started under the European Horizon 2020 programme. The main objective of the TherVacB project is to develop a therapeutic vaccine to cure hepatitis B patients. More than three percent of the world's...
France Biotech: 2nd HealthTech Innovation Days in Paris (2020-02-19)
Unparalleled HealthTech forum helps drive and foster collaborations within the European healthcare and life sciences ecosystems to advance and accelerate patient solutions Launched in 2019 by France Biotech and driven by its successful debut, the second annual...
Cellectis & Servier Expand Collaboration on UCART19 Products (2020-02-18)
Cellectis grants additional rights to Servier to develop and commercialize all next generation gene-edited allogeneic CAR T-cell products targeting CD19, including ALLO-501A Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a biopharmaceutical company focuse...
Stilla Technologies Raises €20m Series B Round (2020-02-11)
Stilla Technologies, a leading provider of pioneering digital PCR (dPCR) solutions for high-precision genetic analysis, has just raised €20 million ($22 million) in a Series B funding round that brought in a new investor, the Chinese group TUS-Holdings, alongside t...
Bayer & Meiogenix = Plant Breeding & Genome Editing (2020-02-10)
Bayer and Meiogenix, a biotech company focused on next-generation breeding technologies, announced today a collaboration to advance agricultural research and development by accelerating the development of Meiogenix’s proprietary technologies related to plant breedi...
MaaT Pharma: €18m Series B for Microbiome Therapeutics (2020-02-05)
Funding enables expansion of clinical program to include additional cancer indications and development of a capsule formulation of MaaT Pharma’s full-ecosystem therapeutic MaaT Pharma announced today an €18 million Series B financing round including a microbio...
Valneva: $85m Debt Financing with Deerfield and OrbiMed (2020-02-03)
The Company also confirms its mid-term intention to list on Nasdaq to co-fund late stage development of its Lyme disease program > Financing Transaction includes initial $60 million fixed rate debt and flexible terms to draw down an additional $25 million in the...
Saga Diagnostics: Cancer CDx for Clinical Trials of Servier (2020-01-28)
SAGA Diagnostics AB, a cancer liquid biopsy and genomic testing company focused on precision oncology and non-invasive ultrasensitive monitoring of cancer patients, today announces it has entered service agreements with the international pharmaceutical company Serv...
Ipsen to Pause Dosing in Palovarotene Ph2/3 Trials (2020-01-24)
> Ipsen has decided to pause dosing in the palovarotene trials > Based on encouraging therapeutic activity signals observed in preliminary post-hoc analyses and recommendations from the Independent Data Monitoring Committee, Ipsen to conduct further assessment ...
PDC*line Raises €13.9m Series B plus €6.1m in Grants & Loans (2020-01-22)
Funding includes €13.9M in equity and €6.1M in grants; will support company’s phase I/II trial with PDC*lung01 candidate in lung cancer PDC*line Pharma, a clinical stage biotech company developing a new class of potent and scalable active immunotherapies for...

Life-Sciences-France.com is your doorway to the French life sciences!

[LSF] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in France and Monaco.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSF] is 100% Made in Germany!

Start here with the latest News!

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

» top